JScreen, a national public health initiative based out of Emory University School of Medicine’s Department of Human Genetics, has established a program that offers at-home testing for more than 60 cancer susceptibility genes associated with hereditary risks for breast, ovarian, prostate, colorectal, skin and other cancers.
A John Hopkins study suggests gaining a better understanding of physical frailty could eventually help people age more healthfully.
The National Comprehensive Cancer Network has published NCCN Guidelines for Histiocytosis.
A study led by Yale Cancer Center and Department of Neurology researchers demonstrated that a blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma.
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell therapy, to reduce the severity of treatment side effects.
City of Hope scientists have combined a checkpoint inhibitor with an anti-parasitic drug, ivermectin, to treat triple-negative breast cancer in preclinical research.
GO2 Foundation for Lung Cancer has created a multi-institutional study to determine how to improve the participation of Black communities in lung cancer clinical trials.
An NCI study demonstrated that people who have had evidence of a prior infection with SARS-CoV-2, the virus that causes COVID-19, appear to be well protected against being reinfected with the virus, at least for a few months.
A study conducted in spring of 2020 demonstrated that one-third of U.S. cancer survivors are worried about treatment and cancer care disruptions during the COVID-19 pandemic.
The National Comprehensive Cancer Network, American Cancer Society Cancer Action Network, and the National Minority Quality Forum have developed recommendations on how to lessen racial disparities in cancer care.
